Cathie Wood’s ARK Invest Ramps Up Rocket Lab and Scribe Therapeutics Buying
TLDR
- ARK Invest bought $25.13 million of Rocket Lab shares on September 22, spread across three ETFs.
- Rocket Lab traded near $70, about 53% below its 52-week high of $151.
- ARK also kept buying Scribe Therapeutics, adding 39,149 shares worth over $1 million on Thursday.
» Read more about: Cathie Wood’s ARK Invest Ramps Up Rocket Lab and Scribe Therapeutics Buying »